Aboudaram, A.; Loap, P.; Loirat, D.; Dhia, S.B.; Cao, K.; Fourquet, A.; Kirova, Y.
Pertuzumab and Trastuzumab Combination with Concomitant Locoregional Radiotherapy for the Treatment of Breast Cancers with HER2 Receptor Overexpression. Cancers 2021, 13, 4790.
https://doi.org/10.3390/cancers13194790
AMA Style
Aboudaram A, Loap P, Loirat D, Dhia SB, Cao K, Fourquet A, Kirova Y.
Pertuzumab and Trastuzumab Combination with Concomitant Locoregional Radiotherapy for the Treatment of Breast Cancers with HER2 Receptor Overexpression. Cancers. 2021; 13(19):4790.
https://doi.org/10.3390/cancers13194790
Chicago/Turabian Style
Aboudaram, Amélie, Pierre Loap, Delphine Loirat, Syrine Ben Dhia, Kim Cao, Alain Fourquet, and Youlia Kirova.
2021. "Pertuzumab and Trastuzumab Combination with Concomitant Locoregional Radiotherapy for the Treatment of Breast Cancers with HER2 Receptor Overexpression" Cancers 13, no. 19: 4790.
https://doi.org/10.3390/cancers13194790
APA Style
Aboudaram, A., Loap, P., Loirat, D., Dhia, S. B., Cao, K., Fourquet, A., & Kirova, Y.
(2021). Pertuzumab and Trastuzumab Combination with Concomitant Locoregional Radiotherapy for the Treatment of Breast Cancers with HER2 Receptor Overexpression. Cancers, 13(19), 4790.
https://doi.org/10.3390/cancers13194790